# Eris Lifesciences acquires 51% stake in Swiss Parenterals for ₹637.5 crore

Eris Lifesciences has acquired a 51% equity stake in Swiss Parenterals Ltd for ₹637.5 crore, with the promoter group acquiring an additional 19%, expanding into sterile injectables and RoW export markets.

- Type: Acquisition
- Announced: 2024-02-13
- Where: Gujarat, India
- Value: $77.0M (6.38B INR)
- Status: announced
- Products: sterile injectable formulations
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Eris Lifesciences](https://endata.com/companies/42256.md) (acquirer)
- [Swiss Parenterals](https://endata.com/companies/75617.md) (target)

## Sources

- [financialexpress.com](https://www.financialexpress.com/business/healthcare-eris-lifesciences-acquires-51-percent-stake-in-swiss-parenterals-to-expand-its-footprint-in-sterile-injectables-3393081/), 2024-02-13: "Eris Lifesciences Ltd., an Indian branded formulations company, on Tuesday announced the expansion of its Sterile Injectables footprint through the acquisition of 51 percent equity stake in Swiss Parenterals Ltd. for a consideration of Rs.637.50 crore."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.